Spike S1 RBD (B.1.617 Variant), Avi-His-Tag (SARS-CoV-2) HiP™ Recombinant

• Description:

  Recombinant SARS-CoV-2 Spike protein, RBD (Receptor Binding Domain) encompassing amino acids 319-541. This protein corresponds to SARS-CoV-2 Variant B.1.617 originally identified in India, and contains mutations L452R and E484K. The construct contains a C-terminal Avi-Tag™ followed by a His-tag (6xHis) . The protein was affinity purified.HiP™indicates a high purity protein (≥90% pure) and less than 10% aggregation as measured by gel filtration.

• UniProt:

  P0DTC2

• Tag:

  C-terminal Avi-His-tag

• Purity:

  ≥ 90%

• Format:

  Aqueous buffer solution

• Shipping Conditions:

  -80°C

• Storage Conditions:

  At least 6 months at -80°C.

• Calculated Molecular Weight:

  28 kDa + glycans

• Formulation:

  8 mM phosphate pH 7.4,110 mM NaCl, 2.2 mM KCl, 20% glycerol

• Aggregation:

  < 10%

• Glycosylation:

  This protein runs at a higher MW by SDS-PAGE due to glycosylation.